Clinical Trials Logo

Neurological Cancer clinical trials

View clinical trials related to Neurological Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT05106725 Recruiting - Brain Cancer Clinical Trials

Wearable Devices and Biomarkers Project (Healthiomics)

Start date: October 11, 2021
Phase:
Study type: Observational

The purpose of this study is to collect clinical data, biological specimens (e.g., blood, tumor, cerebrospinal fluid, urine sample, etc.), and digital health data from patients with tumors, cancer and/or neurological disorders in order to perform research studies that could advance patient care. By collecting these specimens, the investigators plan to create and maintain a biorepository to make data and specimens available to collaborating investigators performing research to discover predictive biomarkers, patterns of care, and personalized treatments that could directly improve the care of our patients through focused proof-of-concept clinical trials.

NCT ID: NCT03922555 Recruiting - Neurological Cancer Clinical Trials

ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Start date: July 12, 2019
Phase: Phase 1
Study type: Interventional

this research study is evaluating the highest dose of ASTX727 that can be administered safely to recurrent/progressive non-enhancing IDH mutant gliomas patients.